---
title: "益豐大藥房連鎖股份有限公司 (603939.SH)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/603939.SH.md"
symbol: "603939.SH"
name: "益豐大藥房連鎖股份有限公司"
industry: "藥品零售商"
---

# 益豐大藥房連鎖股份有限公司 (603939.SH)

| Item | Detail |
|------|--------|
| Industry | 藥品零售商 |
| Location | 滬深市場 |
| Website | [www.yfdyf.cn](https://www.yfdyf.cn) |

## Company Profile

公司是全國大型藥品零售連鎖企業 (中國滬市主板上市連鎖藥房)，市值穩居國內上市連鎖藥店前列，被評為中國上市公司 500 強企業。公司于 2001 年 6 月創立，先后布局醫藥零售、醫藥批發、中藥飲片生產銷售、慢病管理、互聯網醫院、醫療項目投資和醫療科技開發等大健康業態。公司主要從事中西成藥、中藥飲片、醫療器械、保健食品、保健用品、個人護理用品以及與健康相關聯的日化便利、家居清潔等商品的全渠道零售業務。公司主要商品為中西成藥、中藥飲片、醫療器械、保健食品、保健用品、個人護理用品以及與健康相關聯的日化便利、家居清潔等商品。企業榮譽：中國上市公司金牛獎最具投資價值獎、第十二屆中國主板上市公司百強、2...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-21T04:30:10.000Z

**Overall: B (0.39)**

**Industry**: Drug Retail

| Metric | Value |
|--------|-------|
| Industry Ranking | 1 / 9 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 0.88% |  |
| Net Profit YoY | 7.83% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 2.70 |  |
| Dividend Ratio | 2.87% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 29.58B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 24.13B |  |


**Multi Score**: B

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 15.33% | A |
| Profit Margin | 6.81% | B |
| Gross Margin | 41.11% | B |

#### Growth Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 0.88% | C |
| Net Profit YoY | 7.83% | C |
| Total Assets YoY | -4.19% | D |
| Net Assets YoY | 9.02% | B |

#### Cash Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 1468.93% | B |
| OCF YoY | 0.88% | C |

#### Operating Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.91 | A |

#### Debt Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 54.42% | C |


```chart-data:radar
{
  "title": "Longbridge Financial Score - 益豐大藥房連鎖股份有限公司",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "15.33%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "6.81%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "41.11%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "C",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "0.88%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "7.83%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "-4.19%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "9.02%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "B",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "1468.93%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "0.88%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "A",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.91",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "C",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "54.42%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 益豐藥房 (SH.603939) | B | C | A | C | B | B |
| 02 | 華人健康 (SZ.301408) | B | B | A | D | A | B |
| 03 | 第一醫藥 (SH.600833) | C | C | A | C | B | B |
| 04 | 大參林 (SH.603233) | B | C | A | D | B | C |
| 05 | 老百姓 (SH.603883) | C | D | A | D | B | C |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 18.01 | 1/9 | 19.96 | 18.59 | 17.63 |
| PB | 2.70 | 5/9 | 2.99 | 2.78 | 2.61 |
| PS (TTM) | 1.23 | 7/9 | 1.30 | 1.23 | 1.18 |
| Dividend Yield | 2.87% | 4/9 | 3.09% | 2.75% | 2.53% |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-15T16:00:00.000Z

Total Analysts: **14**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 8 | 57% |
| Overweight | 4 | 29% |
| Hold | 1 | 7% |
| Underweight | 1 | 7% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 24.40 |
| Highest Target | 41.46 |
| Lowest Target | 23.40 |

## References

- [Company Overview](https://longbridge.com/en/quote/603939.SH/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/603939.SH/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/603939.SH/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.